Saboo Sodium Chloro Limited has informed BSE Limited about an upcoming board meeting scheduled for March 05, 2026, pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting will focus on fund raising initiatives through a rights issue of equity shares.

Board Meeting Details

The board meeting will be conducted at the company's registered office located at L-5, B-II, Krishna Marg, C-Scheme Jaipur - 302001, Rajasthan, India. The company has outlined specific agenda items for consideration during this meeting.

Rights Issue Proposal

The primary focus of the board meeting will be the consideration and approval of fund raising through rights issue. The company plans to issue equity shares with specific parameters that will be evaluated by the board.

Meeting Agenda

The board will deliberate on several key matters related to the proposed fund raising initiative:

• Rights Issue Approval: Consideration and approval of the proposal for fund raising by way of issue of equity shares of face value of Rs. 10/- each through Rights Issue
• Draft Letter of Offer: Review and approval of the Draft Letter of Offer for fund raising by way of Right issue
• Regulatory Authorization: Authorization for Application for in-principal approval for rights issue up to Rs. 56 crore under Regulation 28(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
• Additional Matters: Any other matter with the permission of the Chair as the Board thinks fit or which is incidental and ancillary to the business of the Company

Regulatory Compliance

The intimation has been made in compliance with SEBI LODR Regulations and has been communicated to BSE Limited. The company has also indicated that this information will be made available on their official website at www.suryasalt.com , ensuring transparency and accessibility for stakeholders.

The communication was signed by Girdhar Saboo, Managing Director (DIN: 00364750), and dated February 27, 2026, providing stakeholders with advance notice of the significant corporate action under consideration.

Saboo Sodium Chloro Limited has announced its unaudited financial results for the third quarter and nine-month period ended December 31, 2025. The Board of Directors approved these results during their meeting held on February 13, 2026, at the company's registered office in Jaipur.

Financial Performance Overview

The company demonstrated solid financial performance during the reporting period. For the third quarter ended December 31, 2025, Saboo Sodium Chloro achieved revenue from operations of ₹1718.96 lacs compared to ₹1428.84 lacs in the corresponding quarter of the previous year.

Segment-wise Performance

The company operates across three main business segments, with salt manufacturing being the primary revenue contributor. The segment-wise revenue breakdown for the third quarter shows salt manufacturing generated ₹1618.58 lacs, while the hotel/resort segment contributed ₹100.40 lacs.

Operational Highlights

The company's total expenses for the quarter amounted to ₹1633.72 lacs, resulting in a profit before tax of ₹85.14 lacs. The company maintained a paid-up equity share capital of ₹4200.11 lacs with a face value of ₹10.00 per share. No tax expense was recorded for the current quarter, and the company reported zero other comprehensive income.

Corporate Governance and Compliance

The financial results were reviewed by the Audit Committee before Board approval. The company's statutory auditors, R.P. Khandelwal & Associates, provided a Limited Review Report confirming that the unaudited financial results comply with applicable accounting standards and regulatory requirements under Regulation 33 of SEBI Listing Regulations.

Additional Information

Saboo Sodium Chloro Limited operates a wholly owned subsidiary, Samskara Resorts Private Limited, which has not yet commenced business operations but is expected to begin after March 2026. The company has adopted Indian Accounting Standards (Ind-AS) as prescribed under the Companies Act 2013 and SEBI regulations for financial reporting.